Magnetic resonance imaging in assessment of rejection of a kidney allograft in the rat: effect of the somatostatin analogue SMS 201-995.
Schuurman
H J
HJ
Sandoz Pharma Ltd., Basel, Switzerland.
Beckmann
N
N
Briner
U
U
Bruns
C
C
Bruttel
K
K
Tanner
M
M
Tolcsvai
L
L
Weckbecker
G
G
D000818:Animals; D016572:Cyclosporine / Q000493:pharmacokinetics / Q000627:therapeutic use; D006084:Graft Rejection / Q000188:drug therapy / Q000473:pathology* / Q000503:physiopathology; D007166:Immunosuppressive Agents / Q000493:pharmacokinetics / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology / Q000473:pathology* / Q000502:physiology; D008279:Magnetic Resonance Imaging; D008297:Male; D015282:Octreotide / Q000493:pharmacokinetics / Q000494:pharmacology*; D051381:Rats; D011917:Rats, Inbred Lew; D011919:Rats, Inbred Strains; D012079:Renal Circulation / Q000187:drug effects; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D015282:Octreotide